Loading
Respiratorius AB (publ) Stock: price and insider trades · Sweden
Respiratorius AB (publ): what insiders have been doing
Respiratorius AB (publ) has a thin disclosure history in our data (latest filing: 26 August 2025). New filings will appear here as soon as they are published. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 2.32
Analyst consensus
Income statement
Gross profit-SEK 8.5k
EBITDA-SEK 3.5M
Net income-SEK 7M0.0% margin
Valuation
P/Book0.6x
Beta1.71
Balance sheet & cash
Market capSEK 18.3M
Free Cash Flow-SEK 7.8M
Profitability & ownership
ROE-24.9%
ROA-15.2%
% insiders18.4%
% institutions8.6%
Last declaration on 26 August 2025
Declarations1 total
108,109 shares0Teckningsrätt/UniträttISIN SE0025938020FI:A003R754-2
1 of 1 declaration
About Respiratorius AB (publ)
Respiratorius AB (publ) is a Swedish company focused on developing treatments for respiratory diseases. It is listed on the Stockholm Stock Exchange under the ticker XSTO.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
